This model, established in other solid tumor entities such as gastric, lung and colorectal cancer, is capable of use to study tissue markers including FOXM1 and allows the investigation of tumor cells in their microenvironment (TME) which could play an important role in assessing drug response and interactions [37,38,39,40]. The gene discussed is FOXM1; the disease is neoplasm.